Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $71.7 million versus the consensus estimate of $59.33 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
- Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
